Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy
Cora N. Sternberg, Fabio Calabrò, Giorgio Pizzocaro, Luca Marini, Sylvia Schnetzer, Avishay Sella
Research output: Contribution to journal › Article › peer-review
207Scopus
citations
Fingerprint
Dive into the research topics of 'Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy'. Together they form a unique fingerprint.